Offerings // CUMBERLAND PHARMACEUTICALS INC

CPIX offering history

Every offering-related filing in CUMBERLAND PHARMACEUTICALS INC’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to Mar 5, 2009.

Last executed offering

Feb 14, 2025

424B5 — priced deal (shares or notes)

Last registration (announced)

Dec 14, 2023

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Feb 14, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 20, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 26, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 14, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 27, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 8, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 11, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 16, 2018	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 9, 2018	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Dec 19, 2017	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Nov 7, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 15, 2012	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 26, 2012	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Sep 25, 2012	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 12, 2009	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Aug 10, 2009	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 29, 2009	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jul 17, 2009	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
May 12, 2009	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Apr 10, 2009	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Mar 18, 2009	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet

CPIX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full CPIX workspace →

CPIX offering FAQ

When did CPIX last execute an offering?

Per SEC filings, CUMBERLAND PHARMACEUTICALS INC's most recent priced offering document is a 424B5 filed 2025-02-14. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did CPIX last announce or register an offering?

The most recent registration is a S-3 filed 2023-12-14. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.